INCB040093

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCB040093, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies [Phase 1]